200,000+ products from a single source!
sales@angenechem.com
Home > Nitro Compounds > 38101-92-7
CAS No: 38101-92-7 Catalog No: AG00JH1S MDL No:MFCD00024000
Title | Journal |
---|---|
PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcoma. | Cancer research 20120901 |
A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells. | Oncology reports 20120301 |
Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma. | PloS one 20120101 |
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111201 |
R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis. | PloS one 20110101 |
© 2019 Angene International Limited. All rights Reserved.